# Biomarin Pharmaceutical Inc: Form 8-K, filed Dec 22, 2025

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: 8-K
- Filed: 2025-12-22
- Accepted by EDGAR: Dec 22, 2025, 09:00 ET
- Period: 2025-12-19
- Accession: 0001193125-25-327828
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000119312525327828/d45090d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000119312525327828/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000119312525327828/d45090d8k.htm

Filed Dec 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-327828. Last ingested by Listed: Nov 4, 2026, 16:43 ET. No prices; not investment advice.
